ROSEANNE HERNANDEZ: Open Payments
NPI 1871201582 · LONG ISLAND CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,168 in 152 payments from 25 companies in 2025. Trend: 2023 $3,095 · 2024 $4,119 · 2025 $5,168
Food & beverage: $5,168
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $938 |
| Lilly USA, LLC | 31 | $844 |
| Corcept Therapeutics | 18 | $504 |
| Amgen Inc. | 13 | $461 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $278 |
| RECORDATI_RARE_DISEASES_INC. | 9 | $278 |
| Madrigal Pharmaceuticals | 5 | $242 |
| Xeris Pharmaceuticals, Inc. | 6 | $211 |
| Insulet Corporation | 1 | $175 |
| Sequel Med Tech, LLC | 1 | $172 |
Products named: JARDIANCE, Korlym, MOUNJARO, Ozempic, ISTURISA, TEPEZZA, REZDIFFRA, EVENITY.
Industry payments across NY — which companies pay providers there.
